BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 11727003)

  • 1. Liver transplantation: evolving patient selection criteria.
    Yu AS; Ahmed A; Keeffe EB
    Can J Gastroenterol; 2001 Nov; 15(11):729-38. PubMed ID: 11727003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient selection criteria for liver transplantation.
    Yu AS; Keeffe EB
    Minerva Chir; 2003 Oct; 58(5):635-48. PubMed ID: 14603144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient selection and listing policies for liver transplantation.
    Keeffe EB
    J Gastroenterol Hepatol; 1999 May; 14 Suppl():S42-7. PubMed ID: 10382638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
    Schaffer RL; Kulkarni S; Harper A; Millis JM; Cronin DC
    Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving trends in liver transplantation: listing and liver donor allocation.
    Wiesner RH
    Clin Liver Dis; 2014 Aug; 18(3):519-27. PubMed ID: 25017073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
    Austin MT; Poulose BK; Ray WA; Arbogast PG; Feurer ID; Pinson CW
    Arch Surg; 2007 Nov; 142(11):1079-85. PubMed ID: 18025337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
    Trotter JF; Osgood MJ
    JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil.
    Pestana RC; Baracat EI; Massarollo PC; Pereira LA; Szutan LA
    Transplant Proc; 2013; 45(6):2111-4. PubMed ID: 23747144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MELD and PELD: application of survival models to liver allocation.
    Wiesner RH; McDiarmid SV; Kamath PS; Edwards EB; Malinchoc M; Kremers WK; Krom RA; Kim WR
    Liver Transpl; 2001 Jul; 7(7):567-80. PubMed ID: 11460223
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver allocation: urgency of need or prospect of success? Ethical considerations.
    Bobbert M; Ganten TM
    Clin Transplant; 2013; 27 Suppl 25():34-9. PubMed ID: 23909500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a continuous disease severity score to the OPTN liver waiting list.
    Edwards EB; Harper AM
    Clin Transpl; 2001; ():19-24. PubMed ID: 12211782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of the allocation system for deceased donor liver transplantation.
    Coombes JM; Trotter JF
    Clin Med Res; 2005 May; 3(2):87-92. PubMed ID: 16012126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases.
    Lucey MR; Brown KA; Everson GT; Fung JJ; Gish R; Keeffe EB; Kneteman NM; Lake JR; Martin P; McDiarmid SV; Rakela J; Shiffman ML; So SK; Wiesner RH
    Liver Transpl Surg; 1997 Nov; 3(6):628-37. PubMed ID: 9404965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic analysis of liver allocation policies.
    Howard DH
    Med Decis Making; 2001; 21(4):257-66. PubMed ID: 11475382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of the MELD score and the UNOS adult liver allocation system.
    Martin AP; Bartels M; Hauss J; Fangmann J
    Transplant Proc; 2007 Dec; 39(10):3169-74. PubMed ID: 18089345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waiting list removal rates among patients with chronic and malignant liver diseases.
    Freeman RB; Edwards EB; Harper AM
    Am J Transplant; 2006 Jun; 6(6):1416-21. PubMed ID: 16686765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era.
    Dutkowski P; Oberkofler CE; Slankamenac K; Puhan MA; Schadde E; Müllhaupt B; Geier A; Clavien PA
    Ann Surg; 2011 Nov; 254(5):745-53; discussion 753. PubMed ID: 22042468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplant recipient selection: MELD vs. clinical judgment.
    Fink MA; Angus PW; Gow PJ; Berry SR; Wang BZ; Muralidharan V; Christophi C; Jones RM
    Liver Transpl; 2005 Jun; 11(6):621-6. PubMed ID: 15915491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescuing Prometheus: a policy proposal to alleviate excess demand for liver transplantation.
    Ferguson ME; Ferguson RM
    Clin Transplant; 1997 Feb; 11(1):49-55. PubMed ID: 9067695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.